Desensitization of the canine A2a adenosine receptor: delineation of multiple processes

TM Palmer, TW Gettys, KA Jacobson and GL Stiles

Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710.

Stable cell lines that express the canine-derived A2a adenosine receptor (A2aAR) have been generated. Using a previously characterized anti-A2aAR antibody probe, we have identified the recombinant receptor protein and examined the desensitization process of this G protein- coupled receptor. Agonist exposure induced a rapid desensitization of A2aAR-stimulated adenylyl cyclase activity. This was associated with reduced affinity of the receptor for the A2aAR-selective agonist [3H]CGS21680 and agonist-stimulated phosphorylation of the receptor protein. Agonist-stimulated A2aAR sequestration into a light membrane fraction was also detected over the same time frame but, whereas inhibition of this process did not affect the extent of desensitization, the rapid recovery normally observed after short term agonist exposure was dramatically reduced. Long term agonist treatment resulted in the down-regulation of A2aARs and up-regulation of Gi alpha 2 and Gi alpha 3, as determined by immunoblotting. Recovery of A2aAR function after agonist removal required several hours and was associated with the return of receptor levels to control values. In contrast, inactivation of Gi proteins by pertussis toxin treatment did not alter the extent of agonist-induced desensitization observed. Neither short nor long term desensitization could be mimicked by elevation of intracellular cAMP levels alone. Therefore, these data suggest that A2aAR desensitization is mediated by multiple, temporally distinct, agonist-dependent processes. Agonist-stimulated phosphorylation of the receptor may induce short term desensitization by impairing receptor-Gs coupling, whereas long term down-regulation of receptor number and up-regulation of inhibitory G proteins mediate long term adaptation.

Volume 45, Issue 6, pp. 1082-1094, 06/01/1994
Copyright © 1994 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				A. Nadeem, M. Fan, H. R. Ansari, C. Ledent, and S. Jamal Mustafa Enhanced airway reactivity and inflammation in A2A adenosine receptor-deficient allergic mice Am J Physiol Lung Cell Mol Physiol, June 1, 2007; 292(6): L1335 - L1344. [Abstract] [Full Text] [PDF]

				A. Haschemi, O. Wagner, R. Marculescu, B. Wegiel, S. C. Robson, N. Gagliani, D. Gallo, J.-F. Chen, F. H. Bach, and L. E. Otterbein Cross-Regulation of Carbon Monoxide and the Adenosine A2a Receptor in Macrophages J. Immunol., May 1, 2007; 178(9): 5921 - 5929. [Abstract] [Full Text] [PDF]

				N. D. Khoa, M. Postow, J. Danielsson, and B. N. Cronstein Tumor Necrosis Factor-{alpha} Prevents Desensitization of G{alpha}s-Coupled Receptors by Regulating GRK2 Association with the Plasma Membrane Mol. Pharmacol., April 1, 2006; 69(4): 1311 - 1319. [Abstract] [Full Text] [PDF]

				M. Klinger, O. Kudlacek, M. G. Seidel, M. Freissmuth, and V. Sexl MAP Kinase Stimulation by cAMP Does Not Require RAP1 but SRC Family Kinases J. Biol. Chem., August 30, 2002; 277(36): 32490 - 32497. [Abstract] [Full Text] [PDF]

				J. Hillion, M. Canals, M. Torvinen, V. Casado, R. Scott, A. Terasmaa, A. Hansson, S. Watson, M. E. Olah, J. Mallol, et al. Coaggregation, Cointernalization, and Codesensitization of Adenosine A2A Receptors and Dopamine D2 Receptors J. Biol. Chem., May 10, 2002; 277(20): 18091 - 18097. [Abstract] [Full Text] [PDF]

				M. D. Okusa A2A adenosine receptor: a novel therapeutic target in renal disease Am J Physiol Renal Physiol, January 1, 2002; 282(1): F10 - F18. [Abstract] [Full Text] [PDF]

				S. V. Sitaraman, M. Si-Tahar, D. Merlin, G. R. Strohmeier, and J. L. Madara Polarity of A2b adenosine receptor expression determines characteristics of receptor desensitization Am J Physiol Cell Physiol, June 1, 2000; 278(6): C1230 - C1236. [Abstract] [Full Text] [PDF]

				S. J. Mundell and J. L. Benovic Selective Regulation of Endogenous G Protein-coupled Receptors by Arrestins in HEK293 Cells J. Biol. Chem., April 21, 2000; 275(17): 12900 - 12908. [Abstract] [Full Text] [PDF]

				M. G. Seidel, M. Klinger, M. Freissmuth, and C. Holler Activation of Mitogen-activated Protein Kinase by the A2A-adenosine Receptor via a rap1-dependent and via a p21ras-dependent Pathway J. Biol. Chem., September 3, 1999; 274(36): 25833 - 25841. [Abstract] [Full Text] [PDF]

				C. Florio, F. Frausin, R. Vertua, and R. M. Gaion Amplification of the Cyclic AMP Response to Forskolin in Pheochromocytoma PC12 Cells through Adenosine A2A Purinoceptors J. Pharmacol. Exp. Ther., August 1, 1999; 290(2): 817 - 824. [Abstract] [Full Text]

				V. Ralevic and G. Burnstock Receptors for Purines and Pyrimidines Pharmacol. Rev., September 1, 1998; 50(3): 413 - 492. [Abstract] [Full Text] [PDF]

				F. Ciruela, C. Saura, E. I. Canela, J. Mallol, C. Lluís, and R. Franco Ligand-Induced Phosphorylation, Clustering, and Desensitization of A1 Adenosine Receptors Mol. Pharmacol., November 1, 1997; 52(5): 788 - 797. [Abstract] [Full Text]

				S. J. Mundell, J. L. Benovic, and E. Kelly A Dominant Negative Mutant of the G Protein-Coupled Receptor Kinase 2 Selectively Attenuates Adenosine A2 Receptor Desensitization Mol. Pharmacol., June 1, 1997; 51(6): 991 - 998. [Abstract] [Full Text]

				T. M. Palmer, T. W. Gettys, and G. L. Stiles Differential Interaction with and Regulation of Multiple G-proteins by the Rat A[IMAGE] Adenosine Receptor J. Biol. Chem., July 14, 1995; 270(28): 16895 - 16902. [Abstract] [Full Text] [PDF]

				E. L. Kilpatrick, P. Narayan, R. M. Mentzer Jr., and R. D. Lasley Cardiac myocyte adenosine A2a receptor activation fails to alter cAMP or contractility: role of receptor localization Am J Physiol Heart Circ Physiol, March 1, 2002; 282(3): H1035 - H1040. [Abstract] [Full Text] [PDF]